The tariff classification of Dimethyl Fumarate Delayed Release Capsules and Meclizine Hydrochloride Tablets in dosage form, from India
Reasoning
The tariff classification of Dimethyl Fumarate Delayed Release Capsules and Meclizine Hydrochloride Tablets in dosage form, from India
Cite this ruling
CBP Ruling N314723 (3004909280): The tariff classification of Dimethyl Fumarate Delayed Release Capsules and Meclizine Hydrochloride Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Tolevamer (code designation: GT267-004), imported in bulk form; Tolevamer 7% Oral Solution, imported put up in 45 mL single-use bottles; and Tolevamer 7% Oral Solution Placebo, imported put up in 45 mL single-use bottles, from Ireland and the United Kingdom
The tariff classification of Stryker® TCP Putty from Ireland
The tariff classification of Bortezomib (CAS-179324-69-7), imported in bulk form, and VELCADE® (bortezomib) for Injection, from Canada and the United Kingdom
The tariff classification of BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5%, supplied in 10mL and 15mL plastic bottles with dropper tips and screw-down caps.
The tariff classification of OCUFLOX® (ofloxacin ophthalmic solution) 0.3%